Our studies showed that treatment of HAECs with aspalatone blocked VEGF-induced endothelial dysfunction by restoring the eNOS levels and inhibiting the expression of inflammatory and adhesion molecules. The gene discussed is VEGFA; the disease is endothelial dysfunction.